Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 5 of 120 for:    COP1

A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00203073
Recruitment Status : Completed
First Posted : September 20, 2005
Last Update Posted : April 14, 2011
Sponsor:
Information provided by:
Teva Pharmaceutical Industries

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2005
Actual Study Completion Date : April 2005